WARRANT AGENT AGREEMENTWarrant Agent Agreement • January 22nd, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
This Warrant Agent Agreement (this “Warrant Agreement”), effective as of [*], 2024 (the “Issuance Date”) is between 60 Degrees Pharmaceuticals, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), and Equity Stock Transfer, LLC, a Nevada limited liability company (the “Warrant Agent”).
COMMON STOCK PURCHASE WARRANTSecurity Agreement • January 22nd, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS CERTIFIES THAT, pursuant to that certain Underwriting Agreement by and between 60 Degrees Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and WallachBeth Capital LLC dated [*], 2024 (the “Underwriting Agreement”), WallachBeth Capital LLC (“Holder”) and its assignees, as registered holders of this purchase warrant (this “Warrant”), is entitled, at any time or from time to time from [*], 2024 (the “Initial Exercise Date”), the date that is one hundred and eighty (180) days after the date of the commencement of the sales of the Company’s Common Stock, $0.0001 par value per share (the “Common Stock”), and at or before 5:00 p.m., Eastern time, on [*], 2029 (five (5) years from the Effective Date) (the “Termination Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [*] shares of Common Stock of the Company (equal to six (6.0%) percent of the Common Stock that are part of the Units sold in the Offering including any exercise of th
UNDERWRITING AGREEMENT [●] Units, Each Consisting of One Share of Common Stock and One Warrant to Purchase One Share of Common Stock; and [●] Pre-Funded Units, Each Consisting of One Pre-Funded Warrant to Purchase One Share of Common Stock and One...Underwriting Agreement • January 22nd, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
An aggregate of [●] Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, $0.0001 par value per share (the “Common Stock”); and (ii) one non-tradeable warrant to purchase one share of Common Stock (the “Firm Non-Tradeable Warrants”); and
